(RGA) Reinsurance of America - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7593516047

RGA: Life, Health, Insurance, Reinsurance, Annuities, Investments

Reinsurance Group of America (RGA) is a leading global reinsurer, playing a crucial role in the insurance ecosystem by managing risk for life and health insurers. They offer a diverse array of products, including term life, whole life, and group life and health insurance, addressing both individual and group needs. Their expertise extends to critical illness, disability, and longevity products, which are vital for insurers seeking to mitigate long-term risks. RGAs role is fundamental in the insurance industry, enabling primary insurers to stabilize their risk exposure and enhance their capital management.

With operations spanning across the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific, RGAs global footprint is a testament to their strategic diversification and market reach. This extensive presence allows them to navigate varying regulatory environments and capitalize on emerging market opportunities, which is advantageous for their risk management strategies and operational resilience.

From a financial standpoint, RGAs market capitalization stands at $15.18 billion, with a trailing P/E ratio of 21.47 and a forward P/E of 8.76, indicating expectations of future earnings growth. Their price-to-book ratio is 1.27, reflecting a modest premium over book value, while the price-to-sales ratio of 0.69 suggests a reasonable valuation relative to their revenue. These metrics provide investors with a clear picture of the companys financial health and valuation metrics.

RGAs commitment to innovation is evident through their technology solutions, which streamline operations and enhance decision-making for their clients. Additionally, their consulting and outsourcing services position them as a comprehensive partner to insurers, offering not just risk management but also operational efficiency. This dual approach of traditional reinsurance and modern technological solutions underscores RGAs strategic evolution and market leadership.

Additional Sources for RGA Stock

RGA Stock Overview

Market Cap in USD 13,382m
Sector Financial Services
Industry Insurance - Reinsurance
GiC Sub-Industry Reinsurance
IPO / Inception 1993-05-04

RGA Stock Ratings

Growth 5y 77.5%
Fundamental 44.6%
Dividend 60.6%
Rel. Strength Industry -12.6
Analysts 4.17/5
Fair Price Momentum 182.36 USD
Fair Price DCF 3279.30 USD

RGA Dividends

Dividend Yield 12m 1.78%
Yield on Cost 5y 4.10%
Annual Growth 5y 4.44%
Payout Consistency 99.3%

RGA Growth Ratios

Growth Correlation 3m -45.2%
Growth Correlation 12m 54%
Growth Correlation 5y 93.8%
CAGR 5y 16.89%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 1.68
Alpha -4.05
Beta 0.63
Volatility 31.58%
Current Volume 793k
Average Volume 20d 557.7k
What is the price of RGA stocks?
As of March 12, 2025, the stock is trading at USD 187.27 with a total of 792,977 shares traded.
Over the past week, the price has changed by -2.99%, over one month by -4.34%, over three months by -10.60% and over the past year by +3.88%.
Is Reinsurance of America a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Reinsurance of America (NYSE:RGA) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.62 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RGA as of March 2025 is 182.36. This means that RGA is currently overvalued and has a potential downside of -2.62%.
Is RGA a buy, sell or hold?
Reinsurance of America has received a consensus analysts rating of 4.17. Therefor, it is recommend to buy RGA.
  • Strong Buy: 5
  • Buy: 4
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for RGA stock price target?
According to ValueRays Forecast Model, RGA Reinsurance of America will be worth about 202 in March 2026. The stock is currently trading at 187.27. This means that the stock has a potential upside of +7.88%.
Issuer Forecast Upside
Wallstreet Target Price 252.7 35%
Analysts Target Price 255.3 36.3%
ValueRay Target Price 202 7.9%